About
Eurofins Discovery provides drug discovery services and products for pharmaceutical, biotechnology, and other research organizations. It supports discovery and development across small molecules, biotherapeutics, integrated drug discovery programs, therapeutic areas, and research phases from global locations including Spain, the US, and India.
Services
Small Molecules
Supports preclinical small molecule programs with target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity assessments.
Assays & in vitro testing
Biotherapeutics
Supports biologics discovery and development from target validation and antigen generation through manufacturability assessment, immunogenicity testing, and preclinical development.
Assays & in vitro testing
Integrated Drug Discovery
Provides an integrated program combining chemistry, biology, ADME, pharmacology, and project management through DiscoveryOne.
Assays & in vitro testing
Therapeutic Areas
Develops assays and models tailored to specific disease areas such as cardiovascular disease, MASH and diabetes, fibrosis, infectious diseases, inflammation, immunology, metabolic disorders, neuroscience, oncology, and orphan diseases.
Assays & in vitro testing
Research Phase
Offers phase-specific assays and services from basic research through target ID and validation, hit finding, hit-to-lead, lead optimization, and pre-clinical candidate selection.
Assays & in vitro testing
Custom Solutions
Modifies and customizes assays and related workflows for small molecule and biotherapeutics discovery needs.
Assays & in vitro testing
LeadHunter target-based assays
Offers off-the-shelf assays against challenging targets for target-based drug discovery.
Assays & in vitro testing
GPCRs
Provides G-protein coupled receptor assays for discovery and screening.
Assays & in vitro testing
Kinases
Provides custom protein production, assay development, screening, and kinase selectivity profiling.
Assays & in vitro testing
Ion Channels
Provides ion channel target investigation and drug safety profiling.
Assays & in vitro testing
Chemistry services
Combines synthetic, computational, medicinal, and analytical chemistry with biology to support drug discovery programs.
Translational Biology
Provides phenotypic drug discovery assays with translationally relevant biomarkers for mechanism of action, efficacy, and toxicity insights.
Assays & in vitro testing
Safety Pharmacology
Provides in vitro safety assays and panels for preclinical candidate assessment.
ADME, DMPK & toxicology
ADME Toxicology
Provides assays to assess absorption, distribution, metabolism, excretion, and potential toxicities.
ADME, DMPK & toxicology
Assay Kits & Reagents
Offers assay kits and reagents for drug discovery and development workflows.
Assays & in vitro testing
Cell-based assay products
Provides cell-based assay products designed to expedite discovery and development.
Assays & in vitro testing
Cell Lines & Primary Cells
Offers cell lines and primary cells for discovery workflows.
Cell line development
Detection Kits & Reagents
Provides detection kits and reagents for assay workflows.
Assays & in vitro testing
Recombinant Proteins & Kinases
Supplies recombinant proteins and kinases for discovery applications.
Protein production
Bioassays for Biologics
Offers bioassays for biologics characterization and development.
Assays & in vitro testing
Membrane Preparations
Provides membrane preparations for assay and screening use.
Assays & in vitro testing
Assay Development
Develops biochemical and cellular assays tailored to project goals.
Assays & in vitro testing
Protein Science
Provides recombinant protein manufacturing for research and drug discovery.
Protein production
Proteomics
Provides proteomics solutions for target evaluation, drug safety, drug repurposing, and cell therapy development.
Cell Line Development & Banking
Outsources cell line development and banking for biomolecule testing and bulk production.
Cell line development
DiscoveryOne project management
Coordinates logistics, invoicing, data formatting, scheduling, and program management for integrated discovery projects.
In Vivo Pharmacology
Customizes in vivo testing for specific study designs or disease models.
ADME, DMPK & toxicology
Targeted Protein Degradation
Supports drug discovery programs focused on targeted protein degradation.
AI-Driven Drug Discovery
Supports AI-enabled drug discovery with wet lab validation.
Target Validation and Antigen Generation
Provides assay development, in vitro pharmacology, reagent generation, and qualification for early biotherapeutics work.
Assays & in vitro testing
- Turnaround
- Fast turnaround times
Capabilities
- Assays and studies
- Small molecules · Antibodies · In vivo · ADME · ADCs · Cell-based assays · Immunogenicity · Cell therapy · Toxicology · Flow cytometry · Biochemical assays · Biophysical characterization
17 more
SPR · Functional assays · Translational assays · In vitro assays · In vivo assays · Target-based assays · Phenotypic assays · Enzyme assays · Radiolabel binding assays · MS binding assays · Immunogenicity testing · Safety assays · Safety pharmacology assays · ADME assays · Immunogenicity assays · DAR analysis · Kinase selectivity profiling - Scale and capacity
- Over 23,000 services and products · Over 10,000 assays · Over 600 ADME/toxicology assays · Over 100 validated infection models · 850+ MIC characterized strains · Over +10,000 assays · Over 600 assays · More than 100 validated infection models · 850+ MIC characterized strains and MDR clinical isolates · Over 40 INDs · Five commercially approved drugs
- Therapeutic areas
- Cardiovascular disease · MASH · Diabetes · Fibrosis · Infectious diseases · Inflammation · Immunology · Metabolic disorders · Neuroscience · Pain · Neurodegenerative diseases · Oncology
6 more
Immuno-oncology · Orphan diseases · CNS disorders · Obesity · Renal disorders · Respiratory diseases
Instruments and platforms
- SPR
- Flow cytometry
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Peptide · mRNA · Viral vector · Cell therapy · Recombinant protein · Vaccine
- Species and models
- Human primary cells · iPSC-derived cardiomyocytes · Rodent models · Human disease models · In vivo animal models · Cell lines · MDR clinical isolates · 850+ MIC characterized strains · SARS-CoV-2
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Company
- Type
- CRO
- Founded
- 1987
- Quality
- Quality Assurance/Quality Control (QA/QC
Locations
- Sites
- Spain · US · India
- Serves
- global
Similar labs
Work here? Claim this listing